The effect of diabetes on the structure and function of insulin receptors was studied in rats 7 d after streptozotocin injection, using solubilized, partially purified receptors from rat hindlimb muscles. Diabetes increased the number of insulin receptors per gram of muscle 60-70% without apparent change in insulin binding affinity. Incubation of receptors at 4 degrees C with [gamma-32P]ATP and insulin resulted in dose-dependent autophosphorylation of the beta-subunit on tyrosine residues; receptors from diabetic rats showed decreased base-line phosphorylation, as well as a decrease in autophosphorylation at maximally stimulating insulin concentrations. These receptors also showed diminished exogenous substrate kinase activity using histone H2b and angiotensin II as phosphoacceptors. The electrophoretic mobility (sodium dodecyl sulfatepolyacrylamide gel electrophoresis) of a subpopulation of beta-subunits derived from diabetics was slightly decreased; differences in electrophoretic mobility between controland diabetic-derived beta-subunits were enhanced by generating fragments by partial Staphylococcus aureus V8 protease digestion. Endoglycosidase-H or neuraminidase treatment increased the electrophoretic mobility of beta-subunits in both groups, but only neuraminidase appeared to decrease or abolish differences in electrophoretic mobility between controls and diabetics, suggesting that excess sialilation may account, in part, for the altered mobility of diabetic derived beta-subunits. All structural and functional alterations in insulin receptors were prevented by treating diabetic rats with insulin for 60 h. 
Introduction
Insulinopenic diabetes in humans is associated with peripheral insulin resistance (1) (2) (3) (4) , which appears to be related to prior glycemic control (5) . Using a closed-loop subcutaneous insulin infusion system, Mayfield et al. (5) reported a direct correlation between elevated hemoglobin (Hb)Alc levels and increased in-sulin requirements in type I diabetic patients. Strict control of blood glucose levels increased the subjects' sensitivity to insulin (5) (6) (7) . Insulin resistance is also seen in animals with experimentally induced insulinopenia. Reaven et al. (8) observed insulin resistance in alloxan diabetic dogs when fasting plasma glucose levels exceeded 150 mg/dl whereas dogs with lower glycemia responded to insulin as the controls. In rodents, streptozotocininduced diabetes results in a diminished response to insulin in isolated adipocytes (9) (10) (11) , liver (12, 13) , as well as skeletal (14) and heart muscle (15) , whereas insulin binding (e.g., the apparent number of insulin receptors) is increased (9, 10, 13) . This has led to the suggestion that the insulin resistance associated with poorly-controlled type I diabetes is primarily a postreceptor defect. Alternatively, it may represent a defect in signal transmission by the occupied insulin receptor.
The initial event in insulin action on target tissues is its binding to specific cell surface receptors. The insulin receptor is a heterotetramer glycoprotein, consisting of two a-and two /3-subunits. The a-subunit with an apparent molecular weight of (MWapp)' -135,000 appears to contain the insulin-binding domain, whereas the 3-subunit MW.p -95,000 may be primarily involved in signal transmission. Insulin binding induces the autophosphorylation of the ,B-subunit in both intact cells and in cell-free systems (16) (17) (18) (19) (20) (21) (22) (23) . After this autophosphorylation, the insulin receptor acquires the ability to act as a kinase toward exogenous substrates (18, 21, 23) . These phosphorylation events occur on tyrosine residues and have been suggested to trigger the phosphorylation-dephosphorylation cascade seen in cells upon exposure to insulin (16, 20, 22) .
Because skeletal muscle is an important site of insulin action, we investigated the effect of streptozotocin-induced diabetes on the functional and structural properties of the solubilized rat skeletal muscle insulin receptor. We found that the insulin-stimulated autophosphorylation and exogenous substrate kinase activity ofdiabetic-derived receptors was impaired. This alteration was reversed by in vivo insulin treatment. The functional changes were paralleled by the appearance of a subpopulation of insulin receptor (3-subunits in diabetic skeletal muscle with a slower electrophoretic migration; the latter may reflect altered glycosylation of the (3- injection of streptozotocin in citrate buffer, pH 4.5, 130 mg/kg of body weight, to overnight fasted animals. In insulin-reversal experiments, diabetic rats were initially treated with 2 U ofregular and 2 U ofprotamine zinc insulin s.c. at 1700 h on the 5th day after streptozotocin and subsequently with 2 U of protamine zinc insulin at 0900 and 1700 h the next 2 d for a total of five treatments. Glycosuria was monitored by TesTape (Eli Lilly Co.) and was 4+ in untreated diabetic rats, and trace, or negative in insulin-treated rats by the 2nd day of treatment. Plasma glucose levels were determined with a Beckman Glucose Analyzer 2 (Beckman Instrument Co., Palo Alto, CA) on blood samples obtained when the animals were killed. Diabetic rats with or without insulin treatment were studied on the 7th day after streptozotocin, and compared to control animals. Rats were killed by decapitation, and the hindlimb muscles were rapidly removed and frozen in liquid nitrogen. Insulin receptors from control and experimental animal groups were always processed on the same day and analyzed in the same experiments.
Solubilization and partial insulin receptor purification were performed as previously described (23). Briefly, the frozen muscles, -5 g, were powdered and membrane components were solubilized by homogenization as a frozen slurry in 4 vol of25 mM Hepes, pH 7.4, 5 mM EDTA, 1 TIU/ml aprotinin, 2 mM phenylmethylsulfonyl fluoride (PMSF), and 1% Triton X-100. The homogenate was centrifuged at 10,000 g for 10 min and the supernate was stirred at room temperature for I h. The mixture was then centrifuged at 150,000 g for 90 min. The receptors were further purified by adsorption to and elution from agarose-bound WGA. Receptors were eluted from the WGA column with 25 mM Hepes, pH 7.4, 0.1% Triton X-100 containing 0.3 M N-acetylglucosamine (-I ml/g of original tissue weight) and used directly or further purified by precipitation with polyclonal antiinsulin receptor antibody. In some preparations 125I-insulin (-1.5 MCi) was added after homogenization of muscles with or without 50 Mg/ml unlabeled insulin. Aliquots were taken at various times during the isolation procedure, and '2I-insulin specifically bound was determined by polyethylene glycol precipitation. Recovery and trichloroacetic acid (TCA) precipitability of the 1251-insulin were determined by counting aliquots in a 'y-counter as described below.
Insulin binding. WGA eluate (50 Ml) was incubated with 10,000 cpm 125I-insulin (sp act 125-175 MCi/Mug, prepared by the lactoperoxidase method as described in Reference 24) and with increasing concentrations ofunlabeled insulin for 16 h at 4°C in a buffer containing 25 mM Hepes, 0.1I% Triton X-100, 150 mM NaCl, 0.1% bovine serum albumin, and 100 U/ml Bacitracin as described by Taylor et al. (25) . The receptor and bound insulin were precipitated by the addition of 100 Ml of0.3% bovine -y-globulin and 300 Ml of 25% polyethylene glycol and collected by centrifugation. The 20 Mul was analyzed on a Perkin-Elmer high performance liquid chromatograph (Perkin-Elmer Corp., Norwalk, CT) using a 5-cm C18 reverse-phase column. ATP was eluted isocratically in a buffer composed of 20 mM phosphoric acid (pH to 6.5 with triethylamine, 98%) and methanol (2%) at a flow rate of 2 ml/min (28 (31) . The washed pellet was oxidized at 25°C for 2 h by the addition of 200 Ml of 9:1 formic acid/H202, diluted to 2 ml with water, and lyophilized. The lyophilizate was resuspended in 0.3 ml of 50 mM (NH4)2C03, pH 8.0, containing 75 Mg/ml L-l-tosylamide-phenylethy chloromethyl ketone (TPCK)-treated trypsin and incubated at 25°C for 12 h when an additional 40Mg of trypsin was added and incubation was continued for another 12 h. The mixture was brought to 3 ml with water and lyophilized three times, resuspending in 3 ml of water each time (31) . Phosphopeptides were separated in two dimensions on 20 cm X 20 cm X 0.1 mm TLC plates by electrophoresis in 1% ammonium bicarbonate, pH 8.9, for 40 min towards the anode and then by ascending chromatography in pyridine/butanol/acetic acid/water (70:50:15:60) in the second dimension (32) . Phosphopeptides were localized by autoradiography at -80°C for 4 h with intensifying screens. Treatment ofimmunoprecipitated receptors with endoglycosidase H. Washed, immunoprecipitated receptors with or without prior partial protease digestion were made 0.1% in SDS and heated for 1 min in boiling water. After cooling, 10 Ml of PIC I and 5 Ml of PIC II were added, followed by 50 M1 of 30 mU/ml endoglycosidase H in 50 mM sodium acetate, pH 5.5, 10mM CaCl2, 0.1% bovine serum albumin and incubated for 4 h at 37°C. The samples were boiled in Laemmli's sample buffer (four-times concentrated) and separated on SDS-PAGE.
Neuraminidase. Immunoprecipitated receptors with or without prior partial V8 digestion were resuspended in 10 Ml of PIC I and 5 Ml of PIC II, followed by the addition of 40 mU/ml neuraminidase in 50 mM sodium acetate, pH 5.0, 10 mM CaC12, and 150 mM NaCI and were incubated 4 h at 37°C. As above the reaction was stopped by the addition of four-times concentrated Laemmli's sample buffer and proteins separated on SDS-PAGE. Methods for treatment of insulin receptors with glycosidases were modified from those described by Ronnett et al. (33) .
Electrophoresis. SDS-PAGE was performed under reducing conditions using the discontinuous buffer system of Laemmli (34) with a 7.5% polyacrylamide resolving gel for nonprotease-digested samples, a 9% polyacrylamide resolving gel for samples previously treated with V8 protease, and a linear 6-18% polyacrylamide resolving gel for reactions containing histone H2b. A 4.5% polyacrylamide stacking gel was used for all samples. Samples were electrophoresed at 150-170 V, constant voltage. Gels were stained, unless indicated, in 50% methanol, 10% acetic acid, and 0.125% Coomassie blue R and destained in 30% methanol and 10% 262 acetic acid. The gels were dried in vacuo and autoradiography was performed with Kodak AR autoradiography film with or without Dupont Lightening + intensifying screens at -80'C.
Results
Animal condition. Rats rendered diabetic by i.p. injection of streptozotocin gained little or no weight during the subsequent 7 d. Final weights of the diabetic rats were 1 1±14 g (n = 23) vs. 164±4 g (n = 15) for the controls. Insulin treatment (60 h) of diabetic rats resulted in rapid weight gain (final weight 145±5 g; n = 10). At the time of sacrifice the plasma glucose concentration of control rats was 130±4 mg/dl (n = 15), that of untreated diabetic rats was 510±14 mg/dl (n = 17), and that of insulin-treated diabetic rats was 94±6 mg/dl (n = 12).
Insulin binding. Equilibrium binding of '251I-insulin by the partially purified insulin receptors extracted from hindlimb muscles of diabetic rats increased approximately twofold per milligram of protein in the wheat germ eluate as compared to controls (Fig. 1 Insulin-stimulated autophosphorylation. Insulin stimulates the autophosphorylation of the insulin receptor through an intramolecular event (20, 35 (Fig. 2) . At maximally stimulating insulin concentrations, the mean autophosphorylation of control receptors was 40% greater than that of the diabetics; however, the insulin-stimulated autophosphorylation over base line (A insulin) was only 20% greater in controls than in diabetics. Although the latter difference was not significant, as will be shown below, it resulted in marked impairment of insulin stimulated exogenous kinase activity. Halfmaximal activation of autophosphorylation occurred at '-2 X 10-9 M insulin in controls and diabetics. When diabetic rats were treated with insulin to normalize their blood glucose levels, the insulin receptors derived from these animals showed nearly identical autophosphorylation kinetics as controls (Fig. 2) .
Exogenous substrate kinase activity: The insulin receptor displays exogenous substrate tyrosyl kinase activity that is activated by the autophosphorylation event (18, 21) . To investigate this property insulin receptors from control, diabetic, or diabetictreated animals were incubated for I h at 25°C with the indicated concentrations of insulin and then allowed to autophosphorylate in the presence of 100 iM [_y-32P]ATP at 40C for 30 min; exogenous kinase activity was then assessed for 5 min at 40C using angiotensin II as the phosphoacceptor. Little exogenous kinase activity was observed in any of the groups in the absence of added insulin. At 10-9 and 10-7 M insulin, a significant decrease in the exogenous substrate kinase activity was seen in the diabetic-derived receptors (P < 0.01, Fig. 3 ). The ability of insulin to stimulate the exogenous kinase activity over basal was significantly less in diabetic-derived receptors than in controls (P < 0.01). Treatment (Fig. 3) . The decreased ability of diabetic-derived receptors to phosphorylate exogenous substrates was not temperature-dependent nor substrate-specific, in that similar decreases in the diabeticderived receptor kinase activity were observed at 25°C using histone H2b as the phosphoacceptor. In these experimenis the wheat germ eluates were preincubated with insulin coupled to agarose, the agarose-bound receptors were extensively washed, and then allowed to fully autophosphorylate in the presence of 750 ,M ATP. The exogenous kinase activity was then assessed using 50 IM [y-32P]ATP. When equal insulin-binding activities derived from control and diabetic muscles were incubated with the beads, there was again a significant decrease in the amount of label incorporated into the histone by the diabetic-derived receptors as compared to the controls (Fig. 4) . When receptors were bound to insulin-agarose beads that had been inactivated with hot dithiothreitol (27) , histone-H2b phosphorylation was -10% of that observed with fully activated agarose-bound receptors (data not shown). 5 shows the phosphoamino acid analysis of control and diabetic-derived insulin receptor f-subunits that were maximally stimulated by insulin and then exposed to 10 MM [y-32P]ATP for 10 min at 25°C. As with other insulin receptors phosphorylated in vitro (18, 19) , labeling occurred predominantly on tyrosine residues in both groups. Although a small amount of serine phosphorylation was observed, it contributed little to the total amount of phosphoamino acid present in either group.
Two dimensional phosphopeptide maps generated from tryspin digestion of the fl-subunit of the insulin receptors derived from control and diabetic animals and autophosphorylated at 25°C are shown in Fig. 6 . Although slight variations occur in the relative labeling of the various phosphopeptides generated by this procedure, no consistent changes occurred in a number of maps analyzed, thus we found no indication that a site or sites are eliminated from the diabetic-derived population that would account for the decrease in overall labeling.
Structure ofthe insulin receptor subunits. Incubation ofwheat germ eluates from control and diabetic animals with A14 1251. insulin with subsequent addition of disuccinimidyl suberate specifically labeled a protein of MWaw 131,000 (Fig. 7) unit ofthe insulin receptor. No differences were observed in the electrophoretic migration of the insulin cross-linked a-subunit between control and diabetic-derived insulin receptor populations. Furthermore, the amount of label bound per receptor was identical when diabetic-and control-derived wheat germ eluates were cross-linked with '25I-insulin. In exploiting the property of autophosphorylation to localize the ,-subunit of the insulin receptor, we investigated the possibility that the functional alterations observed in the insulin receptor from diabetic animals could stem from an identifiable structural alteration in this subunit. Insulin receptors were phosphorylated, immunoprecipitated, and separated under reducing conditions by SDS-PAGE. Autoradiography revealed that the fl-subunit of the insulin receptor derived from diabetic animals included a component that showed a small but reproducible slowing in electrophoretic migration as compared to controls (Fig. 8, lanes A and B) . This change in electrophoretic migration became more prominent after short proteolytic digestion of the phosphorylated, immunoprecipitated receptor with V8 protease (Fig. 8, lanes C and D) . V8 protease treatment reproducibly generated two to four major phosphorylated species each of which showed this altered migration when derived from diabetic muscle.
The major phosphorylated peptides seen after V-8 digestion were shown to be derived from the ,-subunit (as opposed to the variably phosphorylated a-subunit) in the following manner. Phosphorylated, immunoprecipitated insulin receptors were electrophoresed under reducing conditions and the unstained, unfixed gel autoradiographed at 4°C. The fl-subunit was localized and excised, the gel slice placed in a dialysis bag and the phosphoprotein eluted as described in ,sg/ml unlabeled insulin.
We next investigated the possibility that sugar side chains associated with this glycopeptide could be altered in the diabetic state. Considering the difficulty in metabolically labeling the ophilized protein was then subjected to partial V8 digestion, equal numbers of counts from each treatment group (-4,000 cpm) were loaded in each lane and reelectrophoresed. The autoradiograph, (Fig. 8, lanes F and G) shows the same major phosphorylated species as were generated by partial digestion of the immunoprecipitated intact receptor (lanes C and D) with the fragments generated from diabetic-derived ,3-subunits again showing a component with retarded mobility when compared to controls. As shown in Fig. 8 , lanes E and H, the diabetes-associated alteration in electrophoretic mobility was reversed by 60 h of in vivo insulin treatment that normalized blood sugar. Lanes I and J show autoradiograms of control-and diabetic-derived insulin receptors that were immunoprecipitated and partially digested with V-8 protease. Brief autoradiography revealed the diabetic derived 13-subunit (lane J) to consist oftwo distinct populations, one that comigrates with the control receptor (lane I) and one with retarded migration. (Fig. 9 a, lanes A, B and E, F) but did not correct (and actually accentuated) the difference between the control and diabetic. Endoglycosidase H digestion of the immunoprecipitated receptor after partial V8 proteolysis was accomplished by adding an excess of protease inhibitors before the addition of the endoglycosidase. Again a decrease in MWapp of -4,000-5,000 occurred in the major phosphopeptides generated from control-and diabetic-derived ,8-subunits and allowed the separation ofthe diabetic derived receptors into two distinct populations (Fig. 9 b, lanes E and F) , one that comigrates with the control, and one with retarded electrophoretic migration. The decrease in MWp of the p3-subunit after endoglycosidase H treatment suggested that this glycoprotein contains "high mannose" sugar side chains.
Neuraminidase is an exoglycosidase that removes terminal sialic acid residues from the sugar side chains of glycoproteins. When the immunoprecipitated insulin receptor was digested with this enzyme, a decrease in MW.. of -2,000 occurred in control lanes ( Fig. 9 a, lanes A and C) . A similar decrease occurred in the diabetic-derived insulin receptor (Fig. 9 a, lanes B and D) ; in addition, there was an apparent normalization in the electrophoretic migration of this population as compared to control (Fig. 9 a, lanes C and D) . Neuraminidase treatment caused a slight decrease in MW.. ofthe major (-54,000) phosphorylated peptide in the diabetic-derived population (Fig. 9 b, lanes B and  D) , and nearly normalized the migration ofthe diabetic-derived phosphopeptides as compared to control (Fig. 9 b, lanes C and D).
However, double glycosidase digestion, i.e., neuraminidase followed by endoglycosidase H, showed that the second, slower migrating band in the diabetic-derived preparation increased its electrophoretic migration but was not completely eliminated after neuraminidase treatment (Fig. 1O , demonstrating the main -54,000 MWapp phosphopeptide generated by V8 protease digestion). This result raises the possibility that an additional component, possibly "core" sugars, may contribute to the heterogeneity in electrophoretic migration of the diabetic-derived p-subunit. Fig. 7 ). The decrease in autophosphorylation was presumably not due to a decrease in the number of /-subunits in the diabetic-derived wheat germ eluate in that similar binding kinetics were observed and removal of a significant proportion of the insulin receptor /3-subunits would likely result in a noticeable change in receptor affinity. The impairment of insulin-stimulated exogenous kinase activity ofdiabetic-derived receptors (Fig. 3) was more evident than that ofthe insulin activated autophosphorylation (Fig. 2) . Preliminary data (39) The phosphopeptides generated by treating the isolated /3-subunit with TPCK-treated trypsin appeared identical in the diabetic and control muscle-derived receptors. We consistently generated 10 or more phosphopeptides from immunoprecipitated, electroeluted ,3-subunits even after digesting for 72 h. Previous studies utilizing high performance liquid chromatography to separate the products oftrypsin digestion reported the isolation of three to five phosphopeptides (27, 35) . Whether the larger number observed in our system is due to incomplete digestion or to receptor heterogeneity or to the higher sensitivity of autoradiography after two-dimensional peptide separation is not clear. Visual analysis of these maps failed to reveal salient differences in the relative phosphorylation of these fragments between controls and diabetics. The receptors used in generating these maps were phosphorylated for 10 min at 250C in order to maximize 32p incorporation for visualization ofphosphopeptides. However, a more detailed, quantitative examination of the phosphopeptides separated from receptors autophosphorylated at lower temperatures or for shorter time periods at 250C may reveal differences between the two populations.
The presence of a subpopulation of insulin receptor /3-subunits in diabetic rat skeletal muscle with retarded migration on SDS-PAGE suggests that diabetes affects the processing of the insulin receptor in muscle. We were able to detect this subpopulation of receptors in some rats 24 h after streptozotocin injection and in most animals by 3 d. In some animals this slower migrating species comprised up to 50% of the phosphorylated /-subunit band detected by autoradiography. It was difficult to discern this altered population consistently on a 7.5% polyacrylamide gel; however, it became distinct after limited proteolytic digestion of the insulin receptor with V8 protease. This is likely due to the inverse logarithmic relationship between molecular weight and relative mobility on isocratic polyacrylamide gels resulting in improved resolution of smaller proteins, as well as the increased relative preponderance ofthe component with decreased mobility in the fragments. The changes in the insulin receptor /3-subunit structure appear to be in response to insulinopenia and/or resulting changes in the metabolic milieu rather than to toxic effects of streptozotocin in that the slower migrating component was reduced or eliminated by 60 h of insulin treatment which normalized blood sugar. It is interesting to note that -10% ofcontrol animals studied demonstrated a small amount (most <10%) of a higher molecular weight subpopulation.
The glycoprotein nature of the insulin receptor has been demonstrated by direct labeling ofthe sugar moiety (33, 42) and indirectly by its ability to bind to lectins (43) . Ronnett et al. (33) observed that the insulin receptor is synthesized as a single polypeptide chain, which is cleaved and subsequently glycosylated on both the a-and /-subunits. These intermediates are sensitive to endoglycosidase H and neuraminidase resistant. Salzman et al. (44) and Herzberg et al. (45) reported that the mature a-and /-subunits from 3T3-L1 adipocytes and IM-9 lymphocytes contain both endoglycosidase H-sensitive and -insensitive sugar side chains. The latter report also showed that endoglycosidase F could not remove all the sugar side chains from the /3-subunit but treatment with a chemical deglycosylating agent resulted in an additional decrease in molecular weight suggesting the presence of 0-linked side chains. The insulin receptor /3-subunit isolated here from skeletal muscle of control or diabetic rats appeared to be sensitive to digestion by endoglycosidase H; on autoradiography the 95,000-band migrated at -89,000 after endoglycosidase H treatment, suggesting that the /3-subunit isolated from skeletal muscle also contains "high mannose" oli-268 gosaccharide side chains. The peptides generated after V8 digestion, especially the prominent 54,000 band was also endoglycosidase H-sensitive. The diabetic-derived ,3-subunit population separated into two distinct bands after V8 protease and endoglycosidase H treatment, one that comigrated with the control and one with -1,500 higher MW.. (Fig. 8 b) . The further improvement in the resolution of the diabetes induced 13-subunit populations after endoglycosidase H treatment likely reflects the elimination ofoligosaccharides which are known to affect protein migration on SDS-PAGE (46) . Treatment of the immunoprecipitated, insulin receptor populations with neuraminidase increased the migration of the diabetic-derived 13-subunit more than that ofthe control, especially that ofthe prominent 54,000 peptide fragment (Fig. 9) . This suggested that the heterogeneity of the diabetic-derived 1-subunit was due in part to an increase in its sialic acid content. When V8-digested insulin receptors were treated with neuraminidase followed by endoglycosidase H, the more slowly migrating component of the -54,000 fragment (seen in diabetic derived 13-subunits) appeared to decrease in molecular weight whereas the "control band" did not change its migratory behavior (Fig. 10 ). This suggests that there may be an additional sugar side chain on some diabetic-derived 13-subunits or an alteration in the structure of one or more normally occurring oligosaccharide side chains. We encountered difficulties similar to those of Herzberg et al. (45) in attempting to completely remove the oligosaccharide side chains from the 13-subunit with endoglycosidase F or glycanase (broad spectrum N-linked glycosidases [Burant and Buse, unpublished observations] suggesting that the 13-subunit may have 0-linked sugar side chains.
Streptozotocin diabetes results in decreased sialic acid and other carbohydrate content of major glycoproteins on hepatocyte membranes (47) as well as decreased activity of certain glycosyltransferase enzymes, without a detectable change in sialyltransferase activity (48). The insulin receptor, however, is spared from the diabetes-associated decline in hepatic membrane glycoproteins, because hepatic insulin binding and receptor number appear to increase in insulinopenic diabetes (13, 36). The mechanism for the selectivity in hepatic glycoprotein synthesis or degradation is not understood; to our knowledge there is no information concerning the effect of diabetes on glycoprotein turnover or sialyltransferase activity in muscle. We did, however, see in diabetic rats a decline in the amount of glycoprotein per gram of muscle eluted from the wheat germ columns in the insulin receptor purification protocol.
In our studies, there appeared to be a relationship between the appearance ofthe 1-subunit population with decreased electrophoretic mobility and changes in tyrosyl-kinase activity, whenever one phenomenon was detected, so was the other. It tempting to speculate that the metabolic alterations associated with insulin deficiency result in conformational changes in the receptor that renders the coupling between insulin binding and autophosphorylation less efficient. The precise relationship, if any, between the observed alteration in the kinase kinetics in the diabetic-derived insulin receptor and the structural heterogeneity of the 13-subunit remains to be defined. Yamaguchi et al. (49) (50, 51) suggest that postbinding defects may include "intrareceptor" defects, resulting in defective signalling by the receptor in response to hormone binding.
